Is Unicycive Therapeutics, Inc. (UNCY) a Buy, Sell, or Hold?
NASDAQ : UNCY
Unicycive Therapeutics, Inc.
$5.39 USD
$0.39 (7.8%)
- Volume
- 1.5M
- Average Volume
- 1.22M
- Market Capitalization
- $143.91M
- P/E Ratio
- -3.22
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $8.74
- Year Low
- $3.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.81
Company Overview
NASDAQ
Shalabh K. Gupta
Biotechnology
Healthcare
UNCY
21
US
USD
Liquidity Metrics
0.01
3.81
3.81
2.36
0.00
Sales & Valuation
-$
0.00
2.72
-5.17
-1.03
Profitability
-$1.67
-$26.56M
0.00%
0.00%
-88.81%
-48.90%
P/E Metrics
-3.22
-0.22
-0.22
Analyst Price Target & Rating
$22.00
$22.00
$22.00
2/5
8 Analysts
-75.50%
Financial Health Scores
-1.41
2/9
$37.06M
$64.41M
$26.7M
-$39.89M
Key Metrics (TTM)
$97.07M
0.00
-2.47
2.40
-131.18%
-77.54%
-3.34%
-21.48%
-1754 days
Company Executives
| Name | Title |
|---|---|
| Pramod Gupta | Executive Vice President of Pharmaceutical and Business Operations |
| John W. Townsend | Chief Financial Officer |
| Shalabh K. Gupta | Founder, Chairman, Chief Executive Officer & President |
| Douglas Jermasek | Executive Vice President of Corporate Strategy |
Poll Results
No votes yet today — be the first to share your view!
About Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Stock
Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyperphosphatemia in chronic kidney disease patients, and UNI 494, which is being developed to treat acute kidney injury. Founded in 2016, the firm is headquartered in Los Altos, California. ...
Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
2026-08-12 07:19:00
- Company expects to resubmit New Drug Application (NDA) for oxylanthanum carbonate (OLC) assuming completion of successful inspection of third-party manufacturing vendor
2026-07-13 14:05:18
BOSTON, July 13, 2026 (GLOBE NEWSWIRE) -- Block and Leviton is investigating Unicycive Therapeutics, Inc. (Nasdaq: UNCY) for potential securities law violations. Investors who have lost money in their Unicycive Therapeutics, Inc.
2026-07-13 14:05:00
BOSTON, July 13, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Unicycive Therapeutics, Inc. (Nasdaq: UNCY) for potential securities law violations. Investors who have lost money in their Unicycive Therapeutics, Inc. investment should contact the firm to learn more about how they might recover those losses.
2026-07-10 20:00:00
NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ:UNCY) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.
2026-07-08 20:00:00
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ:UNCY) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On June 30, 2026, Unicycive announced that the FDA had issued a second Complete Response Letter (“CRL”) reg.
2026-07-08 12:34:00
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) investors concerning the Company's possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON UNICYCIVE THERAPEUTICS, INC. (UNCY), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
2026-07-08 09:00:00
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN UNICYCIVE THERAPEUTICS, INC. (UNCY), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your.
2026-07-07 18:28:00
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) on behalf of investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON UNICYCIVE THERAPEUTICS, INC. (UNCY), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On June 30, 2026, Unicycive disclosed that the FD.
Frequently Asked Questions
-
What is the current Unicycive Therapeutics, Inc. (UNCY) stock price?
-
Unicycive Therapeutics, Inc.(NASDAQ:UNCY) stock price is $5.39 in the last trading session. During the trading session, UNCY stock reached the peak price of $8.74 while $3.71 was the lowest point it dropped to. The percentage change in UNCY stock occurred in the recent session was 7.8% while the dollar amount for the price change in UNCY stock was $0.39.
-
UNCY's industry and sector of operation?
-
The NASDAQ listed UNCY is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of UNCY?
-
Pramod Gupta | Executive Vice President of Pharmaceutical and Business Operations
John W. Townsend | Chief Financial Officer
Shalabh K. Gupta | Founder, Chairman, Chief Executive Officer & President
Douglas Jermasek | Executive Vice President of Corporate Strategy
| -
How many employees does UNCY have?
-
Number of UNCY employees currently stands at 21. UNCY operates from 1975 West El Camino Real, Mountain View, CA 94040, US.
-
Link for UNCY official website?
-
Official Website of UNCY is: https://www.unicycive.com
-
How do I contact UNCY?
-
UNCY could be contacted at phone #650 351 4495 and can also be accessed through its website. UNCY operates from 1975 West El Camino Real, Mountain View, CA 94040, US.
-
How many shares of UNCY are traded daily?
-
The average number of UNCY shares traded daily for last 3 months was 1.22M.
-
What is the market cap of UNCY currently?
-
The market value of UNCY currently stands at $143.91M with its latest stock price at $5.39